All Stories

  1. Comparison between different prognostic scores in Essential Thrombocythemia

    Article • Hematological Oncology, September 2019, Wiley

    Dr Marco Santoro

  2. Essential thrombocythemia: Biology, clinical features, thrombotic risk, therapeutic options and outcome

    Article • Journal of Hematology and Clinical Research, September 2019, Heighten Science Publications Corporation

    Dr Marco Santoro

  3. Age at diagnosis is an important prognostic factor in Philadelphia‐negative Myeloproliferative Neoplasms

    Article • European Journal Of Haematology, June 2019, Wiley

    Dr Marco Santoro

  4. Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia

    Article • Leukemia & Lymphoma, June 2019, Taylor & Francis

    Dr Marco Santoro

  5. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

    Article • Haematologica, February 2019, Ferrata Storti Foundation (Haematologica)

    Dr Marco Santoro, paola berchialla

  6. Immunosenescence and lymphomagenesis

    Article • Immunity & Ageing, September 2018, Springer Science + Business Media

    Dr Marco Santoro

  7. Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs

    Article • Hematology Reports, March 2018, PAGEPress Publications

    Dr Marco Santoro

  8. Optic disk edema occurring during imatinib treatment in chronic myeloid leukemia.

    Article • Clinical Case Reports, August 2017, Wiley

    Dr Marco Santoro

  9. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: The use of fixed sub-therapeutic doses of low-molecular weight heparin

    Article • American Journal of Hematology, February 2012, Wiley

    Dr Marco Santoro

  10. Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer

    Article • American Journal of Hematology, January 2012, Wiley

    Dr Marco Santoro

  11. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study

    Article • American Journal of Hematology, September 2011, Wiley

    Dr Marco Santoro